Trimazosin

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameTrimazosin
Drug Alias NameCardovarSupresCP-191061CP-23445
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionAlpha adrenergic receptor antagonists
TargetsAlpha adrenergic receptor
Therapy Area/IndicationsHypertension
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusWithdrawn
Highest Status in ChinaN/A
Originator CompaniesPfizer Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesN/A
Active IndicationsN/A
Inactive IndicationsHypertension

Other Information

ATC CodeC02CA03